{"latest_checked": "2026-07-29T22:11:07.860409+00:00", "coverage_count": 5079, "recent_count": 19, "transaction_limit": 160, "filters": {"q": "", "ticker": "FDMT", "sector": "", "industry": "", "side": "", "start": "2026-06-15", "end": "2026-07-30"}, "summary": {"total": 19, "acquisition_count": 10, "disposal_count": 9, "acquisition_value": 81313.84, "acquisition_value_label": "$81.3K", "disposal_value": 2147905.6177, "disposal_value_label": "$2.1M", "net_value": -2066591.7777, "net_value_label": "$-2.1M", "flow_tone": "negative", "largest_value_label": "$1.2M", "top_sector": "Healthcare", "window_label": "15 Jun 2026 to 30 Jul 2026"}, "charts": {"sectors": [{"ticker__sector": "Healthcare", "count": 19, "value": "2229219.4577", "bar_width": 100.0, "sector_slug": "healthcare", "value_label": "$2.2M"}], "days": [{"transaction_date": "2026-06-17", "acquisitions": 7, "disposals": 0, "total": 7, "bar_width": 100.0}, {"transaction_date": "2026-06-22", "acquisitions": 0, "disposals": 1, "total": 1, "bar_width": 14.3}, {"transaction_date": "2026-06-23", "acquisitions": 1, "disposals": 2, "total": 3, "bar_width": 42.9}, {"transaction_date": "2026-06-30", "acquisitions": 2, "disposals": 3, "total": 5, "bar_width": 71.4}, {"transaction_date": "2026-07-09", "acquisitions": 0, "disposals": 1, "total": 1, "bar_width": 14.3}, {"transaction_date": "2026-07-10", "acquisitions": 0, "disposals": 2, "total": 2, "bar_width": 28.6}], "side_mix": {"acquisitions": 10, "disposals": 9, "acquisition_share": 52.6, "disposal_share": 47.4}}, "company_flows": [{"symbol": "FDMT", "name": "4D Molecular Therapeutics\u00a0Inc", "sector": "Healthcare", "industry": "Biotechnology", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/biotechnology/", "latest_transaction": "2026-07-10", "acquisitions": 10, "disposals": 9, "acquired_value": 81313.84, "acquired_value_label": "$81.3K", "disposed_value": 2147905.6177, "disposed_value_label": "$2.1M", "net_value": -2066591.7777, "net_value_label": "$-2.1M", "acquisition_share": 52.6, "disposal_share": 47.4, "detail_url": "https://sharemaestro.com/insider-activity/company/fdmt/", "research_links": {"chart": "/terminal/43122979-d7af-4881-a94a-141f00866826/", "report": "/terminal/43122979-d7af-4881-a94a-141f00866826/report/", "factor": "/factors/ticker/43122979-d7af-4881-a94a-141f00866826/"}}], "company_overview": [{"symbol": "FDMT", "name": "4D Molecular Therapeutics\u00a0Inc", "sector": "Healthcare", "industry": "Biotechnology", "exchange": "NASDAQ", "country": "US", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/biotechnology/", "latest_transaction": "2026-07-10", "filings": 19, "acquisitions": 10, "disposals": 9, "acquired_value": 81313.84, "acquired_value_label": "$81.3K", "disposed_value": 2147905.6177, "disposed_value_label": "$2.1M", "net_value": -2066591.7777, "net_value_label": "$-2.1M", "acquisition_share": 52.6, "disposal_share": 47.4, "tone": "Net acquisition", "tone_class": "positive", "detail_url": "https://sharemaestro.com/insider-activity/company/fdmt/", "research_links": {"chart": "/terminal/43122979-d7af-4881-a94a-141f00866826/", "report": "/terminal/43122979-d7af-4881-a94a-141f00866826/report/", "factor": "/factors/ticker/43122979-d7af-4881-a94a-141f00866826/"}}], "transactions": [{"symbol": "FDMT", "name": "4D Molecular Therapeutics\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-10", "executive": "KIRN, DAVID", "executive_title": "Director, See Remarks", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 15283.0, "share_price": 12.0107, "transaction_value": 183559.5281, "fetched_at": "2026-07-29T21:57:28.100835+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/fdmt/", "research_links": {"chart": "/terminal/43122979-d7af-4881-a94a-141f00866826/", "report": "/terminal/43122979-d7af-4881-a94a-141f00866826/report/", "factor": "/factors/ticker/43122979-d7af-4881-a94a-141f00866826/"}}, {"symbol": "FDMT", "name": "4D Molecular Therapeutics\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-10", "executive": "KIRN, DAVID", "executive_title": "Director, See Remarks", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 442.0, "share_price": 12.8355, "transaction_value": 5673.291, "fetched_at": "2026-07-29T21:57:28.089694+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/fdmt/", "research_links": {"chart": "/terminal/43122979-d7af-4881-a94a-141f00866826/", "report": "/terminal/43122979-d7af-4881-a94a-141f00866826/report/", "factor": "/factors/ticker/43122979-d7af-4881-a94a-141f00866826/"}}, {"symbol": "FDMT", "name": "4D Molecular Therapeutics\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-09", "executive": "KIRN, DAVID", "executive_title": "Director, See Remarks", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 42608.0, "share_price": 12.8656, "transaction_value": 548177.4848, "fetched_at": "2026-07-29T21:57:28.102354+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/fdmt/", "research_links": {"chart": "/terminal/43122979-d7af-4881-a94a-141f00866826/", "report": "/terminal/43122979-d7af-4881-a94a-141f00866826/report/", "factor": "/factors/ticker/43122979-d7af-4881-a94a-141f00866826/"}}, {"symbol": "FDMT", "name": "4D Molecular Therapeutics\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-30", "executive": "BIZILY, SCOTT", "executive_title": "Chief Legal Officer", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 6566.0, "share_price": 14.0, "transaction_value": 91924.0, "fetched_at": "2026-07-20T22:09:20.484900+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/fdmt/", "research_links": {"chart": "/terminal/43122979-d7af-4881-a94a-141f00866826/", "report": "/terminal/43122979-d7af-4881-a94a-141f00866826/report/", "factor": "/factors/ticker/43122979-d7af-4881-a94a-141f00866826/"}}, {"symbol": "FDMT", "name": "4D Molecular Therapeutics\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-30", "executive": "BIZILY, SCOTT", "executive_title": "Chief Legal Officer", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 5752.0, "share_price": 6.49, "transaction_value": 37330.48, "fetched_at": "2026-07-20T22:09:20.486522+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/fdmt/", "research_links": {"chart": "/terminal/43122979-d7af-4881-a94a-141f00866826/", "report": "/terminal/43122979-d7af-4881-a94a-141f00866826/report/", "factor": "/factors/ticker/43122979-d7af-4881-a94a-141f00866826/"}}, {"symbol": "FDMT", "name": "4D Molecular Therapeutics\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-30", "executive": "BIZILY, SCOTT", "executive_title": "Chief Legal Officer", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 814.0, "share_price": 4.14, "transaction_value": 3369.96, "fetched_at": "2026-07-20T22:09:20.480665+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/fdmt/", "research_links": {"chart": "/terminal/43122979-d7af-4881-a94a-141f00866826/", "report": "/terminal/43122979-d7af-4881-a94a-141f00866826/report/", "factor": "/factors/ticker/43122979-d7af-4881-a94a-141f00866826/"}}, {"symbol": "FDMT", "name": "4D Molecular Therapeutics\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-30", "executive": "BIZILY, SCOTT", "executive_title": "Chief Legal Officer", "security_type": "Stock Option (Right to Buy)", "side_code": "D", "side": "Disposal", "shares": 814.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-20T22:09:20.483441+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/fdmt/", "research_links": {"chart": "/terminal/43122979-d7af-4881-a94a-141f00866826/", "report": "/terminal/43122979-d7af-4881-a94a-141f00866826/report/", "factor": "/factors/ticker/43122979-d7af-4881-a94a-141f00866826/"}}, {"symbol": "FDMT", "name": "4D Molecular Therapeutics\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-30", "executive": "BIZILY, SCOTT", "executive_title": "Chief Legal Officer", "security_type": "Stock Option (Right to Buy)", "side_code": "D", "side": "Disposal", "shares": 5752.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-20T22:09:20.481947+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/fdmt/", "research_links": {"chart": "/terminal/43122979-d7af-4881-a94a-141f00866826/", "report": "/terminal/43122979-d7af-4881-a94a-141f00866826/report/", "factor": "/factors/ticker/43122979-d7af-4881-a94a-141f00866826/"}}, {"symbol": "FDMT", "name": "4D Molecular Therapeutics\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-23", "executive": "BIZILY, SCOTT", "executive_title": "Chief Legal Officer", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 9810.0, "share_price": 12.0, "transaction_value": 117720.0, "fetched_at": "2026-07-13T22:04:19.277607+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/fdmt/", "research_links": {"chart": "/terminal/43122979-d7af-4881-a94a-141f00866826/", "report": "/terminal/43122979-d7af-4881-a94a-141f00866826/report/", "factor": "/factors/ticker/43122979-d7af-4881-a94a-141f00866826/"}}, {"symbol": "FDMT", "name": "4D Molecular Therapeutics\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-23", "executive": "BIZILY, SCOTT", "executive_title": "Chief Legal Officer", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 9810.0, "share_price": 4.14, "transaction_value": 40613.4, "fetched_at": "2026-07-13T22:04:19.281192+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/fdmt/", "research_links": {"chart": "/terminal/43122979-d7af-4881-a94a-141f00866826/", "report": "/terminal/43122979-d7af-4881-a94a-141f00866826/report/", "factor": "/factors/ticker/43122979-d7af-4881-a94a-141f00866826/"}}, {"symbol": "FDMT", "name": "4D Molecular Therapeutics\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-23", "executive": "BIZILY, SCOTT", "executive_title": "Chief Legal Officer", "security_type": "Stock Option (Right to Buy)", "side_code": "D", "side": "Disposal", "shares": 9810.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-13T22:04:19.279582+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/fdmt/", "research_links": {"chart": "/terminal/43122979-d7af-4881-a94a-141f00866826/", "report": "/terminal/43122979-d7af-4881-a94a-141f00866826/report/", "factor": "/factors/ticker/43122979-d7af-4881-a94a-141f00866826/"}}, {"symbol": "FDMT", "name": "4D Molecular Therapeutics\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-22", "executive": "KIRN, DAVID", "executive_title": "Director, See Remarks", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 114746.0, "share_price": 10.4653, "transaction_value": 1200851.3138, "fetched_at": "2026-07-13T22:04:19.283145+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/fdmt/", "research_links": {"chart": "/terminal/43122979-d7af-4881-a94a-141f00866826/", "report": "/terminal/43122979-d7af-4881-a94a-141f00866826/report/", "factor": "/factors/ticker/43122979-d7af-4881-a94a-141f00866826/"}}, {"symbol": "FDMT", "name": "4D Molecular Therapeutics\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-17", "executive": "CHACKO, JACOB", "executive_title": "Director", "security_type": "Stock Option (Right to Buy)", "side_code": "A", "side": "Acquisition", "shares": 50000.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-13T22:04:19.296076+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/fdmt/", "research_links": {"chart": "/terminal/43122979-d7af-4881-a94a-141f00866826/", "report": "/terminal/43122979-d7af-4881-a94a-141f00866826/report/", "factor": "/factors/ticker/43122979-d7af-4881-a94a-141f00866826/"}}, {"symbol": "FDMT", "name": "4D Molecular Therapeutics\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-17", "executive": "GRAY, SUSANNAH", "executive_title": "Director", "security_type": "Stock Option (Right to Buy)", "side_code": "A", "side": "Acquisition", "shares": 50000.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-13T22:04:19.292525+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/fdmt/", "research_links": {"chart": "/terminal/43122979-d7af-4881-a94a-141f00866826/", "report": "/terminal/43122979-d7af-4881-a94a-141f00866826/report/", "factor": "/factors/ticker/43122979-d7af-4881-a94a-141f00866826/"}}, {"symbol": "FDMT", "name": "4D Molecular Therapeutics\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-17", "executive": "MILLER-RICH, NANCY", "executive_title": "Director", "security_type": "Stock Option (Right to Buy)", "side_code": "A", "side": "Acquisition", "shares": 50000.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-13T22:04:19.285214+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/fdmt/", "research_links": {"chart": "/terminal/43122979-d7af-4881-a94a-141f00866826/", "report": "/terminal/43122979-d7af-4881-a94a-141f00866826/report/", "factor": "/factors/ticker/43122979-d7af-4881-a94a-141f00866826/"}}, {"symbol": "FDMT", "name": "4D Molecular Therapeutics\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-17", "executive": "MILLIGAN, JOHN F", "executive_title": "Director", "security_type": "Stock Option (Right to Buy)", "side_code": "A", "side": "Acquisition", "shares": 75000.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-13T22:04:19.290750+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/fdmt/", "research_links": {"chart": "/terminal/43122979-d7af-4881-a94a-141f00866826/", "report": "/terminal/43122979-d7af-4881-a94a-141f00866826/report/", "factor": "/factors/ticker/43122979-d7af-4881-a94a-141f00866826/"}}, {"symbol": "FDMT", "name": "4D Molecular Therapeutics\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-17", "executive": "SBLENDORIO, GLENN", "executive_title": "Director", "security_type": "Stock Option (Right to Buy)", "side_code": "A", "side": "Acquisition", "shares": 50000.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-13T22:04:19.289001+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/fdmt/", "research_links": {"chart": "/terminal/43122979-d7af-4881-a94a-141f00866826/", "report": "/terminal/43122979-d7af-4881-a94a-141f00866826/report/", "factor": "/factors/ticker/43122979-d7af-4881-a94a-141f00866826/"}}, {"symbol": "FDMT", "name": "4D Molecular Therapeutics\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-17", "executive": "THEUER, CHARLES", "executive_title": "Director", "security_type": "Stock Option (Right to Buy)", "side_code": "A", "side": "Acquisition", "shares": 50000.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-13T22:04:19.294403+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/fdmt/", "research_links": {"chart": "/terminal/43122979-d7af-4881-a94a-141f00866826/", "report": "/terminal/43122979-d7af-4881-a94a-141f00866826/report/", "factor": "/factors/ticker/43122979-d7af-4881-a94a-141f00866826/"}}, {"symbol": "FDMT", "name": "4D Molecular Therapeutics\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-17", "executive": "TOMASELLO, SHAWN", "executive_title": "Director", "security_type": "Stock Option (Right to Buy)", "side_code": "A", "side": "Acquisition", "shares": 50000.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-13T22:04:19.287248+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/fdmt/", "research_links": {"chart": "/terminal/43122979-d7af-4881-a94a-141f00866826/", "report": "/terminal/43122979-d7af-4881-a94a-141f00866826/report/", "factor": "/factors/ticker/43122979-d7af-4881-a94a-141f00866826/"}}], "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}